Developer docs
API playgroundTry for free, no card

Search company profiles

AppliedVR

Full company profile

uuid0000cqb

Namestring
AppliedVR
Legal namestring
AppliedVR, Inc.
Websiteurl
appliedvr.io
Company typeenum
Private
Founded yearint
2015
Descriptiontext

AppliedVR is a Van Nuys, California-based digital therapeutics company founded in 2015 that develops prescription and wellness virtual reality devices for chronic pain and mental health conditions. Its flagship product, RelieVRx, is the first FDA-authorized prescription-use VR medical device for chronic lower back pain, combining immersive VR experiences with cognitive behavioral therapy techniques to deliver a non-opioid, at-home treatment. A second product, SustainVR, is a general wellness VR device for U.S. Veterans addressing chronic pain, stress, anxiety, PTSD, depression, and sleep, available within the Veterans Affairs healthcare system. The company is supported by an end-to-end care ecosystem including the AVR Pathway patient support program and Companion and Pain Care mobile applications that integrate with Apple Health for progress tracking.

AppliedVR operates a prescription-only, enterprise-focused go-to-market rather than direct-to-consumer. RelieVRx is distributed through durable medical equipment suppliers and specialty pharmacies, and is covered through the VA Federal Supply Schedule, Medicare (via the unique HCPCS Level II code E1905 established in March 2023), commercial insurance (with Highmark becoming the first commercial insurer to cover the device in September 2024), and workers' compensation. Revenue is generated through healthcare-system reimbursement and prescription fulfillment rather than consumer sales, targeting an addressable market of more than 72 million U.S. adults living with chronic lower back pain and a Veterans population in which nearly one in three live with chronic pain.

The company has raised approximately $71 million in total funding (including a $36 million round in November 2021 from F-Prime, Jazz Venture Partners, SVB Capital, Sway Ventures, and others), holds U.S. Patent Nos. 11,073,900 and 11,599,186 covering RelieVRx, and supports its commercial claims with 13 peer-reviewed publications from double-blind randomized controlled trials. The company maintains HIPAA, CCPA, and COPPA compliance, is remote-first with roots in Los Angeles, and employs between 51 and 100 people.

Short descriptiontext

AppliedVR is a digital therapeutics company that develops FDA-authorized prescription virtual reality devices—most notably RelieVRx for chronic lower back pain and SustainVR for Veterans—sold through insurance reimbursement, Medicare, and the VA rather than direct to consumers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersVan Nuys, United States
HQ citystring
Van Nuys
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
virtual reality therapy, digital therapeutics, chronic pain treatment, immersive therapeutics, VR medical devices
Industry2 codes
PRIMARYHLACANAJ
Digital Rehabilitation & Physical Therapy Therapeutics
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAH
Therapeutic Companion Apps (Drug-Device-Digital Combination)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code4 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Offices of Physical, Occupational and Speech Therapists, and Audiologists62134
  • Offices of Physical, Occupational and Speech Therapists, and Audiologists621340
  • Home Health Care Services62161
SIC code3 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
  • Services-Prepackaged Software7372
Product category
Immersive Therapeutics
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Medical Device Sales - RelieVRx
TypeHardware Sales
Description

RelieVRx is sold as a prescription medical device covered by insurance including commercial health plans, Medicare, and VA. Revenue generated through healthcare system reimbursement, insurance coverage contracts, and patient prescriptions fulfilled through durable medical equipment suppliers and specialty pharmacies.

hitconsultant.net
2SustainVR - VA Healthcare
TypeHardware Sales
Description

SustainVR wellness device available within Veteran Affairs healthcare system, generating revenue through government healthcare contracts.

appliedvr.io
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1RelieVRx
Description

FDA-authorized prescription VR medical device for chronic lower back pain - the company's flagship therapeutic product.

appliedvr.io
+2 more records
Core offering1 text field

AppliedVR develops and sells FDA-authorized prescription virtual reality medical devices that deliver immersive cognitive behavioral therapy to treat chronic pain. Its flagship RelieVRx device is the first FDA-authorized prescription VR therapy for chronic lower back pain, sold through healthcare reimbursement channels, while the SustainVR wellness device serves Veterans through the VA system.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Significant, lasting reduction of chronic lower back pain demonstrated in double-blind, randomized, placebo-controlled trial
+2 more records
Product overview1 text field

AppliedVR offers a portfolio of immersive therapeutic products centered around virtual reality technology. The core offerings include RelieVRx, an FDA-authorized prescription VR device for chronic lower back pain, and SustainVR, a general wellness VR device for Veterans. These are supported by the AVR Pathway patient support program and companion mobile applications (Companion and Pain Care apps) that track progress and enhance engagement. The products utilize VR-based cognitive behavioral therapy techniques to deliver drug-free pain management and mental wellness solutions.

Product and service5 records
1RelieVRx
CategoryPrescription VR medical device
Description

RelieVRx is the first FDA-authorized prescription virtual reality medical device for chronic lower back pain. It delivers immersive cognitive behavioral therapy through VR to help patients manage and reduce chronic pain without opioids. Available by prescription only, covered through commercial insurance, Medicare, the VA Federal Supply Schedule, and workers' compensation.

2SustainVR
CategoryVR wellness device
Description

SustainVR is a general wellness VR device offering non-pharmacological, immersive solutions promoting healthy living with chronic pain and mental wellness support for stress, anxiety, PTSD, depression, and sleep improvement. Currently available only within the Veteran Affairs system.

3AVR Pathway
CategoryPatient support program
Description

AVR Pathway is a patient support program that serves as the primary point of contact for patients enrolled in the RelieVRx program, providing technical and non-medical support throughout the treatment journey.

4Companion Mobile Application
CategoryCompanion mobile application
Description

A mobile application that pairs with the RelieVRx device to track therapy progress, display collected health data through Apple Health integration, and support patient engagement with the treatment program.

5Pain Care Mobile Application
CategoryPain management mobile application
Description

A mobile application for pain management support, part of AppliedVR's ecosystem of digital therapeutic products and services.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-09-20
Description

Highmark became the first commercial insurer to cover AppliedVR's RelieVRx for chronic lower back pain treatment, effective September 2024. This partnership provides insurance coverage for AppliedVR's flagship product.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2024-02-08
Description

Joint study announced in February 2024 measuring the impact of VR pain treatment on the brain using Kernel Flow technology. This collaboration evaluates how brain changes during virtual reality treatment of chronic pain.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2023-07-20
Description

Phase 2 clinical trial collaboration with NCI (part of NIH) evaluating VR for reducing anxiety in primary brain tumor patients during imaging services. Interim analysis results announced in July 2023.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1XRHealth
TypeDirect peer
Description

XRHealth offers VR-based telehealth therapy and rehabilitation for chronic pain, anxiety, and physical therapy, directly competing with AppliedVR in immersive therapeutics delivery to patients and providers.

TypeEmerging player
Description

Curable delivers a digital chronic pain program combining education, CBT, and mind-body techniques via app; adjacent to AppliedVR in targeting chronic pain self-management, though without the VR hardware component.

3Sword Health
TypeBroad incumbent
Description

Sword Health is a digital MSK and pelvic health platform serving employers and health plans with clinician-guided virtual care; comparable in addressing chronic pain through alternative-care channels and payer contracts.

TypeOthers
Description

Meta's Quest VR platform underpins much of the consumer-grade VR hardware that AppliedVR-style therapeutics could leverage; it shapes the device ecosystem, content standards, and clinician/patient familiarity relevant to AppliedVR's hardware-delivery model.

TypeDirect peer
Description

Mieron delivers VR-based physical therapy and rehabilitation programs to clinics and patients, overlapping directly with AppliedVR's RelieVRx indication for chronic lower back pain and rehabilitation therapy.

TypeBroad incumbent
Description

Kaia Health offers an app-based digital MSK and chronic pain management program for employers and insurers; serves the same self-insured and payer customers as AppliedVR with a non-VR modality.

TypeDirect peer
Description

BehaVR develops prescription digital therapeutics using VR for chronic pain and behavioral health conditions, closely paralleling AppliedVR's RelieVRx and Immersive Therapeutics platform.

8Pear Therapeutics
TypeOthers
Description

Pear Therapeutics pioneered FDA-authorized prescription digital therapeutics across multiple indications; it is relevant as a benchmark for the regulatory, payer-coverage, and commercialization pathway AppliedVR is pursuing.

TypeBroad incumbent
Description

Hinge Health is a leading digital musculoskeletal platform offering exercise therapy and pain management to employers and payers; it competes for the same chronic pain budget and member relationships, though it does not use VR.

TypeEmerging player
Description

Neuro Rehab VR provides VR-based rehabilitation and therapy solutions for physical and occupational therapy clinics, addressing similar patient populations and use cases as AppliedVR.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles13 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors10 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

AppliedVR

Immersive Therapeuticsappliedvr.io

AppliedVR is a digital therapeutics company that develops FDA-authorized prescription virtual reality devices—most notably RelieVRx for chronic lower back pain and SustainVR for Veterans—sold through insurance reimbursement, Medicare, and the VA rather than direct to consumers.

What AppliedVR does

AppliedVR is a Van Nuys, California-based digital therapeutics company founded in 2015 that develops prescription and wellness virtual reality devices for chronic pain and mental health conditions. Its flagship product, RelieVRx, is the first FDA-authorized prescription-use VR medical device for chronic lower back pain, combining immersive VR experiences with cognitive behavioral therapy techniques to deliver a non-opioid, at-home treatment. A second product, SustainVR, is a general wellness VR device for U.S. Veterans addressing chronic pain, stress, anxiety, PTSD, depression, and sleep, available within the Veterans Affairs healthcare system. The company is supported by an end-to-end care ecosystem including the AVR Pathway patient support program and Companion and Pain Care mobile applications that integrate with Apple Health for progress tracking.

AppliedVR operates a prescription-only, enterprise-focused go-to-market rather than direct-to-consumer. RelieVRx is distributed through durable medical equipment suppliers and specialty pharmacies, and is covered through the VA Federal Supply Schedule, Medicare (via the unique HCPCS Level II code E1905 established in March 2023), commercial insurance (with Highmark becoming the first commercial insurer to cover the device in September 2024), and workers' compensation. Revenue is generated through healthcare-system reimbursement and prescription fulfillment rather than consumer sales, targeting an addressable market of more than 72 million U.S. adults living with chronic lower back pain and a Veterans population in which nearly one in three live with chronic pain.

The company has raised approximately $71 million in total funding (including a $36 million round in November 2021 from F-Prime, Jazz Venture Partners, SVB Capital, Sway Ventures, and others), holds U.S. Patent Nos. 11,073,900 and 11,599,186 covering RelieVRx, and supports its commercial claims with 13 peer-reviewed publications from double-blind randomized controlled trials. The company maintains HIPAA, CCPA, and COPPA compliance, is remote-first with roots in Los Angeles, and employs between 51 and 100 people.

AppliedVR firmographics

Firmographics
Name
AppliedVR
Legal name
AppliedVR, Inc.
Website
https://appliedvr.io
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
51–100 employees
Short description
AppliedVR is a digital therapeutics company that develops FDA-authorized prescription virtual reality devices—most notably RelieVRx for chronic lower back pain and SustainVR for Veterans—sold through insurance reimbursement, Medicare, and the VA rather than direct to consumers.
Ownership category
akta.pro rank

AppliedVR industry classification

Industry
Product category
Immersive Therapeutics
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134), Offices of Physical, Occupational and Speech Therapists, and Audiologists (621340), Home Health Care Services (62161)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841), Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLACANAJ
Digital Rehabilitation & Physical Therapy Therapeutics
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAH
Therapeutic Companion Apps (Drug-Device-Digital Combination)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • Virtual reality therapy
  • Digital therapeutics
  • Chronic pain treatment
  • Immersive therapeutics
  • VR medical devices

Where AppliedVR is headquartered

Location

Headquarters

HQ city
Van Nuys
HQ country
United States
HQ region
North America

Offices1 record

Markets served

AppliedVR business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Operations

Revenue model

  1. Medical Device Sales - RelieVRx: RelieVRx is sold as a prescription medical device covered by insurance including commercial health plans, Medicare, and VA. Revenue generated through healthcare system reimbursement, insurance coverage contracts, and patient prescriptions fulfilled through durable medical equipment suppliers and specialty pharmacies.
  2. SustainVR - VA Healthcare: SustainVR wellness device available within Veteran Affairs healthcare system, generating revenue through government healthcare contracts.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

AppliedVR product offering

Product offering

Core offering

AppliedVR develops and sells FDA-authorized prescription virtual reality medical devices that deliver immersive cognitive behavioral therapy to treat chronic pain. Its flagship RelieVRx device is the first FDA-authorized prescription VR therapy for chronic lower back pain, sold through healthcare reimbursement channels, while the SustainVR wellness device serves Veterans through the VA system.

Product overview

AppliedVR offers a portfolio of immersive therapeutic products centered around virtual reality technology. The core offerings include RelieVRx, an FDA-authorized prescription VR device for chronic lower back pain, and SustainVR, a general wellness VR device for Veterans. These are supported by the AVR Pathway patient support program and companion mobile applications (Companion and Pain Care apps) that track progress and enhance engagement. The products utilize VR-based cognitive behavioral therapy techniques to deliver drug-free pain management and mental wellness solutions.

Differentiator

Problem solved

Functional benefit

Brands

  • RelieVRx: FDA-authorized prescription VR medical device for chronic lower back pain - the company's flagship therapeutic product.
  • SustainVR
  • AVR Pathway

Products and services

  • RelieVRx RelieVRx is the first FDA-authorized prescription virtual reality medical device for chronic lower back pain. It delivers immersive cognitive behavioral therapy through VR to help patients manage and reduce chronic pain without opioids. Available by prescription only, covered through commercial insurance, Medicare, the VA Federal Supply Schedule, and workers' compensation.
  • SustainVR SustainVR is a general wellness VR device offering non-pharmacological, immersive solutions promoting healthy living with chronic pain and mental wellness support for stress, anxiety, PTSD, depression, and sleep improvement. Currently available only within the Veteran Affairs system.
  • AVR Pathway AVR Pathway is a patient support program that serves as the primary point of contact for patients enrolled in the RelieVRx program, providing technical and non-medical support throughout the treatment journey.
  • Companion Mobile Application A mobile application that pairs with the RelieVRx device to track therapy progress, display collected health data through Apple Health integration, and support patient engagement with the treatment program.
  • Pain Care Mobile Application A mobile application for pain management support, part of AppliedVR's ecosystem of digital therapeutic products and services.

Quantifiable outcome

  • Significant, lasting reduction of chronic lower back pain demonstrated in double-blind, randomized, placebo-controlled trial
  • +2 more outcomes

Companies that use AppliedVR

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

AppliedVR technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature3 records

AppliedVR partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and major.

  • HighmarkcoreChannel Partner/ Reseller/ Distributor · 20 September 2024Highmark became the first commercial insurer to cover AppliedVR's RelieVRx for chronic lower back pain treatment, effective September 2024. This partnership provides insurance coverage for AppliedVR's flagship product.
  • KernelmajorStrategic or Co-development Partner · 8 February 2024Joint study announced in February 2024 measuring the impact of VR pain treatment on the brain using Kernel Flow technology. This collaboration evaluates how brain changes during virtual reality treatment of chronic pain.
  • National Cancer Institute (NCI)majorStrategic or Co-development Partner · 20 July 2023Phase 2 clinical trial collaboration with NCI (part of NIH) evaluating VR for reducing anxiety in primary brain tumor patients during imaging services. Interim analysis results announced in July 2023.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

AppliedVR competitors and assessment

Company assessment

Direct peers

  • XRHealth: XRHealth offers VR-based telehealth therapy and rehabilitation for chronic pain, anxiety, and physical therapy, directly competing with AppliedVR in immersive therapeutics delivery to patients and providers.
  • Mieron: Mieron delivers VR-based physical therapy and rehabilitation programs to clinics and patients, overlapping directly with AppliedVR's RelieVRx indication for chronic lower back pain and rehabilitation therapy.
  • BehaVR: BehaVR develops prescription digital therapeutics using VR for chronic pain and behavioral health conditions, closely paralleling AppliedVR's RelieVRx and Immersive Therapeutics platform.

Emerging players

  • Curable: Curable delivers a digital chronic pain program combining education, CBT, and mind-body techniques via app; adjacent to AppliedVR in targeting chronic pain self-management, though without the VR hardware component.
  • Neuro Rehab VR: Neuro Rehab VR provides VR-based rehabilitation and therapy solutions for physical and occupational therapy clinics, addressing similar patient populations and use cases as AppliedVR.

Broad incumbents

  • Sword Health: Sword Health is a digital MSK and pelvic health platform serving employers and health plans with clinician-guided virtual care; comparable in addressing chronic pain through alternative-care channels and payer contracts.
  • Kaia Health: Kaia Health offers an app-based digital MSK and chronic pain management program for employers and insurers; serves the same self-insured and payer customers as AppliedVR with a non-VR modality.
  • Hinge Health: Hinge Health is a leading digital musculoskeletal platform offering exercise therapy and pain management to employers and payers; it competes for the same chronic pain budget and member relationships, though it does not use VR.

Others

  • Meta (Reality Labs): Meta's Quest VR platform underpins much of the consumer-grade VR hardware that AppliedVR-style therapeutics could leverage; it shapes the device ecosystem, content standards, and clinician/patient familiarity relevant to AppliedVR's hardware-delivery model.
  • Pear Therapeutics: Pear Therapeutics pioneered FDA-authorized prescription digital therapeutics across multiple indications; it is relevant as a benchmark for the regulatory, payer-coverage, and commercialization pathway AppliedVR is pursuing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

AppliedVR social profiles

Digital presence

AppliedVR compliance and trust

Trust signal

Compliance3 records

AppliedVR financial estimates

Financial estimate

Revenue estimate

Valuation estimate

AppliedVR leadership team

Management profile

Number of profiles

Profiles13 records

AppliedVR funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

AppliedVR M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AppliedVR

What does AppliedVR do?

AppliedVR develops and sells FDA-authorized prescription virtual reality medical devices that deliver immersive cognitive behavioral therapy to treat chronic pain. Its flagship RelieVRx device is the first FDA-authorized prescription VR therapy for chronic lower back pain, sold through healthcare reimbursement channels, while the SustainVR wellness device serves Veterans through the VA system.

Is AppliedVR a public or private company?

AppliedVR is a private company. It is classified as venture growth investor backed and is currently operating.

When was AppliedVR founded?

AppliedVR was founded in 2015. It employs 51 to 100 people.

Where is AppliedVR based?

AppliedVR is headquartered in Van Nuys, United States, in the North America region.

How does AppliedVR make money?

Two revenue lines are on record. Medical Device Sales - RelieVRx is the primary driver. The others are sustainVR - VA Healthcare.

Who are AppliedVR's main competitors?

Direct peers on record are XRHealth, Mieron and BehaVR. Emerging players are Curable and Neuro Rehab VR. Broad incumbents are Sword Health, Kaia Health and Hinge Health. Others are Meta (Reality Labs) and Pear Therapeutics.

Does AppliedVR have an API?

No public API is recorded for AppliedVR.

What industry is AppliedVR in?

AppliedVR's product category is Immersive Therapeutics. Its primary akta.pro industry code is HLACANAJ, Digital Rehabilitation & Physical Therapy Therapeutics, with a secondary code of HLACANAH, Therapeutic Companion Apps (Drug-Device-Digital Combination). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
SNS InsiderDigital Therapeutics for Chronic Pain Management Market Size, Share & Growth, 2026-2035The global Digital Therapeutics for Chronic Pain Management Market was valued at USD 5.21 billion in 2025 and is projected to reach USD 64.01 billion by 2035, expanding at a CAGR of 28.52% during the forecast period 2026-2035, driven by increasing adoption of AI-enabled platforms, wearable devices, and non-opioid pain management solutions. North America held approximately 46% of the market share in 2025, while the Asia Pacific region is expected to record the fastest growth at a CAGR of 33.03%. Key players including AppliedVR, Hinge Health, Sword Health, and Click Therapeutics have been actively expanding their digital therapeutic offerings, though market growth faces constraints from inconsistent reimbursement frameworks and complex regulatory requirements.openPR.comTrends in Growth, Segment Analysis, and Competitive Approaches Influencing the Overactive Bladder Treatment MarketThe overactive bladder treatment market is projected to reach $4.21 billion by 2030, growing at a compound annual growth rate of 5.4%, driven by digital health adoption, minimally invasive treatments, and telemedicine expansion. In January 2024, Boston Scientific announced its $3.7 billion acquisition of Axonics Inc., strengthening its neuromodulation portfolio with sacral neuromodulation technologies for bladder and bowel dysfunction treatment. The article also highlights emerging VR therapy applications, with AppliedVR's RelieVRx system receiving a Healthcare Common Procedure Coding System Level II code in March 2023.PharmiWeb.comAugmented Reality (AR) and Virtual Reality (VR) in Healthcare Market Growth, Opportunities, Sales, Trends service, applications and forecast 2029The global AR and VR healthcare market is projected to grow at a CAGR of 30–35%, driven by technological advancements, healthcare digitization, supportive government initiatives, and rising venture capital investment. Notable milestones include Stanford Medicine's first spine surgery using Surgical Theater's SyncAR technology, CAE Healthcare's launch of an enhanced CathLabVR training platform, and FDA approval of AppliedVR's EaseVRx for chronic pain management. North America currently dominates the market, with Europe emerging as a high-growth region supported by initiatives such as the European Commission's Virtual and Augmented Reality Industrial Coalition.FortunebusinessinsightsVirtual Reality in Healthcare MarketThe global virtual reality in healthcare market is projected to grow from USD 3.12 billion in 2023 to USD 46.37 billion by 2032, exhibiting a CAGR of 35.1%, with North America accounting for 37.5% of the market in 2023. In May 2024, Sony Group Corporation completed a strategic collaboration with Siemens to introduce VR headsets for the industrial metaverse ecosystem by December 2024, currently integrated with Siemens' engineering design platform NX. Key industry players including Philips, AppliedVR, and GE Healthcare are actively forming partnerships and developing advanced VR solutions to reinforce their market positions.GlobeNewswireNew Research Published: VR Therapy Provides Greater ReliefAppliedVR published a study in Scientific Reports on its FDA-authorized RelieVRx VR therapy for chronic lower back pain, based on a trial of over 1,000 participants. The therapy produced clinically meaningful pain relief, with 70% of high-impact chronic pain patients transitioning to lower-impact status, and 67% maintaining that status 12 months later.TradingViewNew Research Published: VR Therapy Provides Greater Relief for Hard-to-Treat PatientsAppliedVR published a study in Scientific Reports on its FDA-authorized RelieVRx VR therapy for chronic lower back pain, focusing on high-impact chronic pain patients. The secondary analysis of over 1,000 participants found 70% of HICP patients transitioned to lower-impact status, with 67% maintaining it 12 months later. The findings suggest sustained benefits and potential cost savings for healthcare systems.GlobeNewswireNew Research Published: VR Therapy Provides Greater ReliefAppliedVR published a study in Scientific Reports on its FDA-authorized RelieVRx VR therapy for chronic lower back pain, based on a trial of over 1,000 participants. The therapy produced clinically meaningful pain relief, with 70% of high-impact chronic pain patients transitioning to lower-impact status, and 67% maintaining that status 12 months later.MobiHealthNewsQ&A: The state of medical XR in 2025AppliedVR's Josh Sackman discussed the medical XR industry's state in 2025, citing payer adoption and reimbursement as key success factors. He noted consolidation is likely as companies face financing challenges, and expects momentum to pick up in the first two quarters.YouTubeAppliedVR's Transformative Virtual Experience for Pain ManagementOrthogonal's Chief Solution Officer Randy Horton interviewed AppliedVR founder and president Josh Sackman about the company's therapeutic virtual reality treatments for chronic pain. AppliedVR's flagship RelieVRx combines cognitive behavioral therapy, mindfulness, biofeedback and neuroscience into a 56-session program, with reimbursement secured from the VA and a Northeast healthcare plan. The company is working with CMS on codes and prices and pursuing a De Novo FDA pathway.